Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,659Revenue (TTM) $M186Net Margin (%)-17.0Altman Z-Score1.6
Enterprise Value $M4,897EPS (TTM) $-0.2Operating Margin %-73.6Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.0Pre-tax Margin (%)-16.1Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio3.2Cash flow > EarningsN
Price/Sales24.85-y EBITDA Growth Rate %--Current Ratio3.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-5.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M194ROIC % (ttm)-99.8Gross Margin Increase y-yY

Gurus Latest Trades with ARIA

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

ARIA is held by these investors:

ARIA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bollag Daniel MSr. VP, Reg. Affairs & Quality 2017-01-09Sell32,000$23.780.88view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-10-24Sell19,638$9.56150.94view
Bollag Daniel MSr. VP, Reg. Affairs & Quality 2016-10-03Sell47,384$13.4678.23view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-09-28Sell8,750$13.9871.6view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-09-22Sell20,000$13.4378.63view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-09-15Sell59,369$11.73104.52view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-08-22Sell19,436$10.47129.13view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-08-12Sell25,000$10.5128.48view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-07-22Sell18,286$8.11195.81view
Cole Hugh MSVP, Chief Business Officer 2016-06-28Sell6,012$7.05240.28view

Quarterly/Annual Reports about ARIA:

News about ARIA:

Articles On GuruFocus.com
Michael Price Invests in 11 Companies in First Quarter May 19 2015 
Sarah Ketterer of Causeway Capital's Answers to GuruFocus Q&A Apr 07 2014 
Weekly CEO Sells Highlight: U.S. Bancorp, Restoration Hardware Holdings Inc, Ariad Pharmaceuticals, Jul 20 2013 
Daniel Loeb's Top Three Increases of the First Quarter May 24 2013 
Weekly CFO Sales Highlight: WWWW, FIO, CRIS, ARIA, VOG, APKT Apr 22 2012 
3 Biotech Stocks To Consider Buying Right Now Jan 10 2012 
ARIAD Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
ARIAD Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 10 2009 
Weekly CEO Buys Highlight: Citigroup Inc, ARIAD Pharmaceuticals Inc, Bruker BioSciences Corp, Akamai Aug 08 2009 

More From Other Websites
Former Ariad CEO joins a familiar face on board of The Medicines Co., hinting at a sale Apr 06 2017
Amgen's Blincyto sBLA Secures FDA Priority Review Mar 30 2017
Who Is Incyte Collaborating With? Mar 01 2017
Two Great Stock Ideas in the IBB Biotech ETF Feb 15 2017
ARIAD Files for EU Approval of Lung Cancer Drug Brigatinib Feb 07 2017
Why Ariad Pharmaceuticals Stock Nearly Doubled in January Feb 06 2017
Ariad Submits Marketing Application to EU Agency Feb 06 2017
ARIAD Announces Submission of Marketing Authorization Application for Brigatinib to the European... Feb 06 2017
Blog Coverage Exelixis Partners with Takeda to Commercialize and Develop Novel Cancer Therapy... Feb 01 2017
Ariad mum on layoffs in letter to employees: ‘It’s business as usual’ Jan 25 2017
Ariad Put Off Potential Suitor Amid 'Aggressive' Takeda Bid: RBC Jan 20 2017
Ariad played hardball to boost Takeda buyout price, federal filings show Jan 20 2017
Biotech Stocks Might Catalyze, Or Plunge, On 4 Key Sectors In 2017 Jan 20 2017
Can The Uptrend Continue for ARIAD Pharmaceuticals (ARIA)? Jan 20 2017
5 Expensive Drugs That Could End Up in Trump's Crosshairs Jan 18 2017
Ariad Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of ARIA Shareholders Jan 18 2017
Jazz Begins Phase III Study for Label Expansion of Defitelio Jan 18 2017
Becton, Dickinson Commercially Launches Precise WTA Kits Jan 18 2017
These 3 Stocks Have Doubled Since Election Day Jan 17 2017
ARIAD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of ARIAD Pharmaceuticals,... Jan 13 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)